Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Vitamin D and the racial difference in the genotype 1 chronic hepatitis C treatment response.

The American journal of clinical nutrition - 1 Nov 2012

Weintraub Steven J, Fleckenstein Jacquelyn F, Marion Tony N, Madey Margaret A, Mahmoudi Tahar M, Schechtman Kenneth B

Abstract excerpt

BACKGROUND: African Americans with genotype 1 chronic hepatitis C attain a sustained virologic response (SVR) at only approximately one-half the rate of whites after peginterferon and ribavirin treatment. The serum concentration of 25-hydroxyvitamin D [25(OH)D] has recently been established as a predictor of treatment response. Therefore, the low serum concentrations of 25(OH)D found among African Americans may...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Black or African American

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Logistic Models

Share to Polyethylene Glycols

Share to Ribavirin

Share to Vitamin D

Source

Open in PubMed Open full text

Identifiers

PMID: 23015322
DOI: 10.3945/ajcn.112.039974
PMCID: PMC3471194

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Vitamin D and the racial difference in the genotype 1 chronic hepatitis C treatment response.PMID 23015322Read ↗

Sustained virological response rate to pegylated interferon plus ribavirin for chronic hepatitis C in African Americans: results in treatment-naïve patients in a university liver clinic.Semantic proximity Read ↗

Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites.Semantic proximity Read ↗

Associations between serum lipids and hepatitis C antiviral treatment efficacy.Semantic proximity Read ↗

Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infection.Semantic proximity Read ↗

African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians.Semantic proximity Read ↗

Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.Semantic proximity Read ↗

Optimum ribavirin exposure overcomes racial disparity in efficacy of peginterferon and ribavirin treatment for hepatitis C genotype 1.Semantic proximity Read ↗

Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1.Semantic proximity Read ↗

Black patients with chronic hepatitis C have a lower sustained viral response rate than non-Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin*.Semantic proximity Read ↗

Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States.Semantic proximity Read ↗

Factors influencing treatment outcome in hepatitis C virus minority patients at an inner-city hospital: A STROBE-complaint article.Semantic proximity Read ↗

Effect of vitamin D supplementation on pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b: a randomized controlled trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.